VVOS
Vivos Therapeutics, Inc.
Going-concern doubt
— flagged May 20, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Without additional financing, these factors raise substantial doubt regarding the Company’s ability to continue as a going concern.”View the 10-Q filed May 20, 2026
Company with tickers: VVOS
CIK
1716166
CUSIP
92859E207
Shares Outstanding
13,894,600
Website
https://www.vivos.com
Investor Relations
https://vivos.com/investors/
13F Activity (30d)
2 filings
1 filers
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $5,141,000 | USD | 2026-03-31 | 10-Q | 2026-05-20 |
| Cost of Revenue | — | ||||
| Gross Profit | $3,059,000 | USD | 2026-03-31 | 10-Q | 2026-05-20 |
| Operating Expenses | $9,674,000 | USD | 2026-03-31 | 10-Q | 2026-05-20 |
| Research & Development | — | ||||
| Operating Income | $-6,615,000 | USD | 2026-03-31 | 10-Q | 2026-05-20 |
| Net Income | $-7,682,000 | USD | 2026-03-31 | 10-Q | 2026-05-20 |
| EPS (Basic) | $-0.52 | USD/shares | 2026-03-31 | 10-Q | 2026-05-20 |
| EPS (Diluted) | $-0.52 | USD/shares | 2026-03-31 | 10-Q | 2026-05-20 |
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
By Product & Service (USD)
| Component | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|---|
| Sleep Testing Services | — | $594,000 | $1,185,000 | $1,282,000 | $6,041,000 |
| Appliances | — | — | $6,081,000 | $5,601,000 | $3,277,000 |
| Tooth Positioners | — | — | — | $2,273,000 | $3,210,000 |
| Treatment Centers | — | — | — | — | $2,179,000 |
| Sponsorship Seminar Other | $289,000 | $114,000 | $676,000 | $1,941,000 | $1,222,000 |
| Billing Intelligence Services | $905,000 | $1,170,000 | $887,000 | $840,000 | $686,000 |
| VIP | $8,517,000 | $4,838,000 | $3,922,000 | $2,485,000 | $491,000 |
| Myofunctional Therapy Services | $341,000 | $927,000 | $861,000 | $609,000 | $337,000 |
| Product | — | $8,381,000 | $6,270,000 | $7,874,000 | — |
| Service | — | $7,643,000 | $7,531,000 | $7,157,000 | — |
| Appliance Sales To VIP | $6,040,000 | $7,820,000 | $6,081,000 | — | — |
| Center Revenue | $480,000 | $561,000 | $189,000 | — | — |
| Guides | — | — | $189,000 | $2,273,000 | — |
| Management Service Revenue | $313,000 | $63,000 | — | — | — |